![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
A 2-Way Steady State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir
|
|
|
Reported by Jules Levin
16th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy (IWCPHIVHT) May 26-28, 2015 Washington, DC, USA
Matt S Anderson,1 Sauzanne Khalilieh,1 Ka Lai Yee,1 Rachael Liu,1 Li Fan,1
Matthew L Rizk,1 Vedangi Shah,1 Azra Hussaini,2 Ivy Song,3 Lisa Ross,4
Joan R Butterton1
1Merck & Co., Inc., Kenilworth, NJ, USA; 2PAREXEL, Baltimore, MD, USA; 3GlaxoSmithKline, Research Triangle Park, NC, USA; 4ViiV Healthcare, Research Triangle Park, NC, USA
![Pharm1.gif](../images/060915/060815-7/Pharm1.gif)
![Pharm2.gif](../images/060915/060815-7/Pharm2.gif)
![Pharm3.gif](../images/060915/060815-7/Pharm3.gif)
![Pharm4.gif](../images/060915/060815-7/Pharm4.gif)
![Pharm5.gif](../images/060915/060815-7/Pharm5.gif)
![Pharm6.gif](../images/060915/060815-7/Pharm6.gif)
![Pharm7.gif](../images/060915/060815-7/Pharm7.gif)
![Pharm8.gif](../images/060915/060815-7/Pharm8.gif)
![Pharm9.gif](../images/060915/060815-7/Pharm9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|